TAILOR-PANC: Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer (DPCG-02)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07802418

Title field or adapter rule

{'original_value': 'TAILOR-PANC: Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer (DPCG-02)', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:26.586740+00:00

Published At

2026-09-03T00:00:00+00:00

Record Updated At

2026-09-03

Source Retrieved At

2026-10-31T22:17:58.991924+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-03", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07802418"

protocolSection.identificationModule.officialTitle

"TAILOR-PANC: Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer (DPCG-02)"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Arm 1: Molecularly Tailored Therapy'], 'description': 'Axitinib Crizotinib Dabrafenib Trametinib Erlotinib Larotrectinib Olaparib Pembrolizumab Pemigatinib Pertuzumab and trastuzumab (Phesgo9 Selpercatinib Vismodegib', 'name': 'Arm 1: Molecularly Tailored Therapy', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm 2: Standard-of-Care Therapy'], 'description': 'Gemcitabine Nab-paclitaxel 5-Fluorouracil; 5-FU Calcium folinate Oxaliplatin Irinotecan Capecitabine', 'name': 'Arms 2: Standard-of-Care Therapy', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Arm 3: Standard-of-Care Observational Cohort'], 'description': 'Gemcitabine Nab-paclitaxel 5-Fluorouracil; 5-FU Calcium folinate Oxaliplatin Irinotecan Capecitabine', 'name': 'Arm 3: Standard-of-Care Observational Cohort', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Arm 1: Molecularly Tailored Therapy (protocolSection.armsInterventionsModule.interventions[].name)
• Arms 2: Standard-of-Care Therapy (protocolSection.armsInterventionsModule.interventions[].name)
• Arm 3: Standard-of-Care Observational Cohort (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.